Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1

Overview of attention for article published in Frontiers in oncology, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 21 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 32,936 followers.

RT @exosome: More on WEE1 .. “Reducing Wee1 activity results in ectopic activation of CDK1 activity and drives premature entry into mitosi…

20 Apr 2022

Reply Repost Favourite

More on WEE1 .. “Reducing Wee1 activity results in ectopic activation of CDK1 activity and drives premature entry into mitosis with unrepaired or under-replicated DNA and causing mitotic catastrophe. https://t.co/axVW8FzEZF

17 Apr 2022

Reply Repost Favourite

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1 https://t.co/fi4NH4VVl4

07 Mar 2022

Reply Repost Favourite

RT @amirocytosis: Our review on targeting the Wee1 kinase for cancer therapy is finally out in @FrontOncology : https://t.co/DbQKGzwJM3 #DN…

21 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.